The GABAA receptor is known to be the site of action for a variety of drugs with hypnotic, anaesthetic and anticonvulsant properties (see Reviews, Bormann, 1988; Sieghart, 1992; Macdonald and Olsen, 1994; Smith and Olsen, 1995) . The function of the GABAA receptor is also modulated by intracellular substances, such as Ca2+ in DRG neurons (Inoue et al. 1986; Taleb et al. 1987; Behrends et al. 1988; Llano et al. 1991; Kano et al. 1992; Mulle et al. 1992 ) and ATP in guinea pig hippocampai neurons and chick spinal cord neurons (Gyenes et al. 1988 (Gyenes et al. , 1994 Stelzer et al. 1988; Shirasaki et al. 1992) . Phosphorylation and dephosphorylation of receptorassociated chloride channels have been considered as an important step in the modulation of GABAA receptor function (Nestler and Greengard, 1984; Stelzer et al. 1988; Chen et al. 1990; Chen and wong, 1995) . Recently, it was reported that substance P (SP) inhibited a GABAinduced inward current in primary afferent neurons of the bullfrog dorsal root ganglia (DRG) (Yamada and Akasu, 1996 , 1995) . It has been shown that SP produces an inward current by suppressing the M-current through an activation of a G-protein in frog sympathetic ganglia (Pfaffinger, 1988; Lopez and Adams, 1989) and bullfrog DRG neurons (Ishimatsu, 1994) . Pfaffinger (1988) has demonstrated that the SP-induced inhibition of IM occurs independent of PKC but is mediated directly by a G-protein. The present study demonstrates that the SP-induced inhibition of IGABA was blocked by a PKC inhibitor, H-7. Although db-cyclic AMP and forskolin, an adenylyl cyclase activator, depressed the IGABA; a PKA inhibitor, H-9, did not prevent the SP-induced inhibition of the IGABA. It can be concluded that the SP-induced inhibition of the IGABA is mediated by a diffusible messenger, probably PKC. There are several reports relating to the signal transduction pathway for the SP effect. SP accelerates the turnover of inositol polyphosphate metabolism by activating phospholipase C (PLC) (Hanley et al. 1980; Watson and Downes, 1983; Pfaffinger, 1988) . A G-protein may activate PLC, and an increase in PLC activity can lead to the activation of PKC via diacylglycerol (Nishizuka et al. 1991 
